Skip to the main content

ADMET and DMPK, Vol. 13 No. 5, 2025.

Original scientific paper

https://doi.org/10.5599/admet.2961

Elucidating CYP2D6-driven metabolism and hepatotoxic bioactivation of metoprolol in plateable human and animal hepatocytes

Jiang Pu ; Bioduro Biologics Co., Ltd., Shanghai, China *
Mei Yang ; Bioduro Biologics Co., Ltd., Shanghai, China
Min Zhang ; Bioduro Biologics Co., Ltd., Shanghai, China
Ruiqi Gao ; Bioduro Biologics Co., Ltd., Shanghai, China
Yue Xiao ; Bioduro Biologics Co., Ltd., Shanghai, China
Lingyu Liu ; Bioduro Biologics Co., Ltd., Shanghai, China
Chuanjing Zhang ; Bioduro Biologics Co., Ltd., Shanghai, China
Wennuo Xu ; Bioduro Biologics Co., Ltd., Shanghai, China
Kaifang Li ; Bioduro Biologics Co., Ltd., Shanghai, China
Wanyong Feng ; Bioduro Biologics Co., Ltd., Shanghai, China

* Corresponding author.

Full text: english pdf 1.346 Kb

downloads: 17

cite

Abstract

Background and purpose: As a classic β-blocker with low systemic clearance, metoprolol has been linked to rare but clinically significant hepatotoxicity, yet its hepatic metabolic fate remains poorly characterized. Experimental approach: Metoprolol was incubated individually in plateable human and animal hepatocytes, and recombinant cytochrome (CYP) P450 enzymes, followed by sample processing for cytotoxicity assessment, stability analysis, phenotyping and metabolite identification studies. Key results: In vitro cytotoxicity assessment revealed distinct species-specific responses to metoprolol exposure. Metoprolol showed no observable cytotoxicity across the tested concentration range (0 to 500 µM) in human hepatocytes, whereas it was cytotoxic only at a concentration of 500 µM in rat hepatocytes. Metabolic characterization showed low intrinsic clearance in human hepatocytes (0.56±0.12 µL min-1 per million cells) over a 72-hour incubation. Comprehensive mass spectrometer analysis identified 22 metabolites across four species (rat, dog, monkey, and human) and fifteen metabolites were identified as the new ones, with CYP2D6-mediated biotransfor­ma­tion pathways (including mono-oxygenation, O-demethylation, and oxidation) accounting for the generation of four major metabolites (M1, M10, M13, M17). Notably, species-specific metabolism was observed for a-hydroxy-metoprolol (M10). It served as the predominant metabolite in rat hepatocytes and underwent subsequent bioactivation to a reactive glutathione (GSH) conjugate. Inhibition studies with 1-aminobenzo­triazole (a non-specific CYP inhibitor) confirmed the CYP-dependent nature of this hepatotoxic metabolic pathway. Conclusion: The sustained metabolic activity of plateable hepatocytes facilitated a comprehensive metabolic profiling of metoprolol, including direct observation of GSH-mediated bioactivation. Integrating with cytotoxicity data, these findings offered crucial insights into its hepatic adverse effects.

Keywords

Metabolite; cytotoxicity; recombinant; low-clearance; glutathione; CYP2D6

Hrčak ID:

338684

URI

https://hrcak.srce.hr/338684

Publication date:

30.10.2025.

Visits: 33 *